Share value of the generic pharmaceuticals market in Norway 2000-2017

Market share of generic pharmaceuticals in Norway from 2000 to 2017

by F. Norrestad, last edited Dec 19, 2018
Share value of the generic pharmaceuticals market in Norway 2000-2017 This statistic displays the share value of the generics market as a proportion of the total pharmaceutical market in Norway from 2000 to 2017. In 2017, the market share reached its highest value of 17.7 percent of the total pharmaceutical market.
Show more

Market share of generic pharmaceuticals in Norway from 2000 to 2017

Loading statistic...
Share value of generics market
201717.7%
201617.2%
201516%
201416.2%
201316.8%
201217%
201116.5%
201016.4%
200915.5%
200814.8%
200713.7%
200613.3%
200512.5%
200412.5%
200312.1%
200210.4%
200110.4%
200010.7%
Share value of generics market
201717.7%
201617.2%
201516%
201416.2%
201316.8%
201217%
201116.5%
201016.4%
200915.5%
200814.8%
200713.7%
200613.3%
200512.5%
200412.5%
200312.1%
200210.4%
200110.4%
200010.7%
Download Settings Share
Download started
Please be patient - this may take a moment
by F. Norrestad, last edited Dec 19, 2018
This statistic displays the share value of the generics market as a proportion of the total pharmaceutical market in Norway from 2000 to 2017. In 2017, the market share reached its highest value of 17.7 percent of the total pharmaceutical market.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Generics and biosimilars"
  • Global overview
The most important statistics
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.